PHGE - BiomX Inc.

NYSE American - Nasdaq Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
6/29/2019
Total Revenue
0
0
Cost of Revenue
-
-
Gross Profit
-
-
Operating Expenses
Research Development
-
-
Selling General and Administrative
-
-
Total Operating Expenses
1,023
405
Operating Income or Loss
-1,023
-405
Interest Expense
-
-
Total Other Income/Expenses Net
-
-6
Income Before Tax
239
483
Income Tax Expense
183
135
Income from Continuing Operations
56
347
Net Income
56
347
Net Income available to common shareholders
-220
347
Reported EPS
Basic
-
0.15
Diluted
-
0.15
Weighted average shares outstanding
Basic
-
1,996
Diluted
-
1,996
EBITDA
-
-405